Sector: Pharmaceutical PreparationsIndustry: BiotechnologyCountry: USExchange: Nasdaq
DilutionScan read 36 of Decoy Therapeutics Inc.'s SEC filings and found 15 warrant series, 6 convertibles, 1 ATM program, 1 equity line, 2 shelf registrations, 5 S-1 registrations and 3 completed offerings on file for DCOY. The latest dilution event on file is a registration statement on Oct 16, 2026. Analysis updated Nov 1, 2026.
DilutionScan ProEvery instrument in full ยท $59/mo
Covered companies in Biotechnology. All tickers A to Z
NRSNNeuroSense Therapeutics Ltd. Ordinary Shares
BIXTBioxytran, Inc.
ACUTAccustem Sciences Inc.
CLDICalidi Biotherapeutics, Inc.
HCWBHCW Biologics Inc.
ABPOAbpro Holdings, Inc.
MBIOMustang Bio, Inc.
SILOSilo Pharma, Inc.
REVBRevelation Biosciences, Inc.
ONCOOnconetix, Inc.
VIVSVivoSim Labs, Inc.
BDRXBiodexa Pharmaceuticals plc American Depositary Shs
CODXCo-Diagnostics, Inc.
MDCXMedicus Pharma Ltd. Common Stock
ENLVEnlivex Ltd. Ordinary Shares